Agency Forms Undergoing Paperwork Reduction Act Review, 70151-70153 [2020-24474]
Download as PDF
<![CDATA[
Federal Register / Vol. 85, No. 214 / Wednesday, November 4, 2020 / Notices
assets or the ownership of, control of, or
the power to vote shares of a bank or
bank holding company and all of the
banks and nonbanking companies
owned by the bank holding company,
including the companies listed below.
The public portions of the
applications listed below, as well as
other related filings required by the
Board, if any, are available for
immediate inspection at the Federal
Reserve Bank(s) indicated below and at
the offices of the Board of Governors.
This information may also be obtained
on an expedited basis, upon request, by
contacting the appropriate Federal
Reserve Bank and from the Board’s
Freedom of Information Office at
https://www.federalreserve.gov/foia/
request.htm. Interested persons may
express their views in writing on the
standards enumerated in the BHC Act
(12 U.S.C. 1842(c)).
Comments regarding each of these
applications must be received at the
Reserve Bank indicated or the offices of
the Board of Governors, Ann E.
Misback, Secretary of the Board, 20th
Street and Constitution Avenue NW,
Washington, DC 20551–0001, not later
than December 4, 2020.
A. Federal Reserve Bank of
Minneapolis (Chris P. Wangen,
Assistant Vice President), 90 Hennepin
Avenue, Minneapolis, Minnesota
55480–0291:
1. Security Bancshares Company,
Glencoe, Minnesota; to acquire voting
shares of Flagship Financial Group, Inc.,
Eden Prairie, Minnesota, and thereby
indirectly acquire Flagship Bank
Minnesota, Wayzata, Minnesota.
Board of Governors of the Federal Reserve
System, October 30, 2020.
Michele Taylor Fennell,
Deputy Associate Secretary of the Board.
[FR Doc. 2020–24439 Filed 11–3–20; 8:45 am]
BILLING CODE 6210–01–P
DEPARTMENT OF DEFENSE
GENERAL SERVICES
ADMINISTRATION
khammond on DSKJM1Z7X2PROD with NOTICES
NATIONAL AERONAUTICS AND
SPACE ADMINISTRATION
[OMB Control No. 9000–0001; Docket No.
2020–0053; Sequence No. 14]
Information Collection; Standard Form
28, Affidavit of Individual Surety
Department of Defense (DOD),
General Services Administration (GSA),
and National Aeronautics and Space
Administration (NASA).
AGENCY:
VerDate Sep<11>2014
18:16 Nov 03, 2020
Jkt 253001
A. OMB Control Number, Title, and
Any Associated Form(s)
Notice and request for
comments.
ACTION:
In accordance with section
3506(c)(2)(A) of the Paperwork
Reduction Act of 1995, and the Office of
Management and Budget (OMB)
regulations, DoD, GSA, and NASA
invite the public to comment on a
revision and renewal concerning the
Standard Form 28, Affidavit of
Individual Surety. DoD, GSA, and
NASA invite comments on: Whether the
proposed collection of information is
necessary for the proper performance of
the functions of Federal Government
acquisitions, including whether the
information will have practical utility;
the accuracy of the estimate of the
burden of the proposed information
collection; ways to enhance the quality,
utility, and clarity of the information to
be collected; and ways to minimize the
burden of the information collection on
respondents, including the use of
automated collection techniques or
other forms of information technology.
OMB has approved this information
collection for use through February 28,
2021. DoD, GSA, and NASA propose
that OMB extend its approval for use for
three additional years beyond the
current expiration date.
SUMMARY:
DoD, GSA, and NASA will
consider all comments received by
January 4, 2021.
DATES:
DoD, GSA, and NASA
invite interested persons to submit
comments on this collection through
https://www.regulations.gov and follow
the instructions on the site. This website
provides the ability to type short
comments directly into the comment
field or attach a file for lengthier
comments. If there are difficulties
submitting comments, contact the GSA
Regulatory Secretariat Division at 202–
501–4755 or GSARegSec@gsa.gov.
Instructions: All items submitted
must cite OMB Control No. 9000–0001,
Standard Form 28, Affidavit of
Individual Surety. Comments received
generally will be posted without change
to https://www.regulations.gov, including
any personal and/or business
confidential information provided. To
confirm receipt of your comment(s),
please check www.regulations.gov,
approximately two-to-three days after
submission to verify posting.
ADDRESSES:
FOR FURTHER INFORMATION CONTACT:
Zenaida Delgado, Procurement Analyst,
at telephone 202–969–7207, or
zenaida.delgado@gsa.gov.
SUPPLEMENTARY INFORMATION:
PO 00000
Frm 00025
Fmt 4703
Sfmt 4703
70151
9000–0001, Standard Form 28,
Affidavit of Individual Surety.
B. Need and Uses
This clearance covers the information
that offerors or contractors must submit
to comply with the following Federal
Acquisition Regulation (FAR)
requirement:
• Standard Form (SF) 28, Affidavit of
Individual Surety.
This form is used by all executive
agencies, including the Department of
Defense (DoD), to obtain information
from individuals wishing to serve as
sureties to Government bonds. Offerors
and contractors may use an individual
surety as security for bonds required
under a solicitation or contract for
supplies or services (including
construction). It is an elective decision
on the part of the offeror or contractor
to use individual sureties instead of
other available sources of surety or
sureties for Government bonds.
The contracting officer uses the
information on the SF 28 to determine
the acceptability of individuals
proposed as sureties.
C. Annual Burden
Respondents: 10.
Total Annual Responses: 20.
Total Burden Hours: 6.
Obtaining Copies: Requesters may
obtain a copy of the information
collection documents from the GSA
Regulatory Secretariat Division by
calling 202–501–4755 or emailing
GSARegSec@gsa.gov. Please cite OMB
Control No. 9000–0001, Standard Form
28, Affidavit of Individual Surety.
William F. Clark,
Director, Office of Government-wide
Acquisition Policy, Office of Acquisition
Policy, Office of Government-wide Policy.
[FR Doc. 2020–24417 Filed 11–3–20; 8:45 am]
BILLING CODE 6820–EP–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30Day–21–1215]
Agency Forms Undergoing Paperwork
Reduction Act Review
In accordance with the Paperwork
Reduction Act of 1995, the Centers for
Disease Control and Prevention (CDC)
has submitted the information
collection request titled Awardee Lead
Profile Assessment (ALPA) to the Office
E:\FR\FM\04NON1.SGM
04NON1
70152
Federal Register / Vol. 85, No. 214 / Wednesday, November 4, 2020 / Notices
of Management and Budget (OMB) for
review and approval. CDC previously
published a ‘‘Proposed Data Collection
Submitted for Public Comment and
Recommendations’’ notice on July 20,
2020 to obtain comments from the
public and affected agencies. CDC did
not receive comments related to the
previous notice. This notice serves to
allow an additional 30 days for public
and affected agency comments.
CDC will accept all comments for this
proposed information collection project.
The Office of Management and Budget
is particularly interested in comments
that:
(a) Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
(b) Evaluate the accuracy of the
agencies estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and
clarity of the information to be
collected;
(d) Minimize the burden of the
collection of information on those who
are to respond, including, through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses; and
(e) Assess information collection
costs.
To request additional information on
the proposed project or to obtain a copy
of the information collection plan and
instruments, call (404) 639–7570.
Comments and recommendations for the
proposed information collection should
be sent within 30 days of publication of
this notice to www.reginfo.gov/public/
do/PRAMain. Find this particular
information collection by selecting
‘‘Currently under 30-day Review—Open
for Public Comments’’ or by using the
search function. Direct written
comments and/or suggestions regarding
the items contained in this notice to the
Attention: CDC Desk Officer, Office of
Management and Budget, 725 17th
Street NW, Washington, DC 20503 or by
fax to (202) 395–5806. Provide written
comments within 30 days of notice
publication.
Proposed Project
Awardee Lead Profile Assessment
(ALPA) (OMB Control No. 0920–1215,
Exp. 02/28/2021)—Revision—National
Center for Environmental Health
(NCEH), Centers for Disease Control and
Prevention (CDC).
Background and Brief Description
The Centers for Disease Control and
Prevention (CDC) is requesting
Paperwork Reduction Act (PRA)
clearance for a three-year revised
information collection request (ICR)
titled ‘‘Awardee Lead Profile
Assessment (ALPA)’’ (OMB Control No.
0920–1215; expiration date 02/28/2021).
The goal of this ICR is to build on the
CDC’s existing childhood lead
poisoning prevention program. Based on
program successes over the past three
years, CDC has made ALPA an annual
reporting requirement for ongoing and
new CDC Childhood Lead Poisoning
Prevention Programs (CLPPPs),
including the FY17 ‘‘Lead Poisoning
Prevention—Childhood Lead Poisoning
Prevention—financed partially by
Prevention and Public Health Funds’’
(CDC–RFA–EH17–1701PPHF17); the
FY18 ‘‘Childhood Lead Poisoning
Prevention Projects, State and Local
Childhood Lead Poisoning Prevention
and Surveillance of Blood Lead Levels
in Children’’ (CDC–RFA–EH18–1806);
and the FY20 ‘‘Childhood Lead
Poisoning Prevention and Surveillance
of Blood Lead Levels in Children’’
(CDC–RFA–EH20–2001). This annual
information collection will be used to;
(1) identify common characteristics of
funded childhood lead poisoning
prevention programs, and (2) inform
guidance and resource development in
support of the ultimate program goal,
which is blood lead elimination in
children.
The dissemination of these ALPA
results will ensure that both funded and
non-funded jurisdictions are able to; (1)
identify policies and other factors that
support or hinder childhood lead
poisoning prevention efforts; (2)
understand what strategies are being
used by funded public health agencies
to implement childhood lead poisoning
prevention activities; and (3) use this
knowledge to develop and apply similar
strategies to support the national agenda
to eliminate childhood lead poisoning.
This program management
information collection has been revised
in several ways. Due to an increase in
funding and program growth, CDC is
requesting an increase in the number of
respondents, defined as state and local
governments, or their bona fide agents.
CDC will continue to use two data
collection modes, a web survey and an
email survey. We anticipate that most of
the respondents (n=60; 98 percent) will
use the web survey. The estimates of the
number and percentage of respondents
by mode of data collection are based on
previous data collections. In the past,
respondents only used the email survey
if they had technical difficulties with
the web survey, which was rare. For this
purpose, we estimate that only 2% (n=1)
of the respondents may need to submit
an email survey. This represents a
change in distribution from the 2018
estimates, which were initially assumed
as 83.3% for the web survey and 16.7%
for the email survey.
A redistribution by mode of collection
will not affect the total time burden
requested as the time per response is the
same for either mode; however, the time
to take the survey has increased from
seven minutes in 2018 to 47 minutes per
response due to a revision of the survey.
This revised time estimate per response
is based on pilot tests of the revised
survey among nine respondents, and
includes the time needed to review the
ALPA Training Manual, which is a new
addition in this revision ICR.
Thus, CDC is requesting an increase
in the annual number of respondents
from 48 to a maximum of 61 recipients
(n=13 more respondents), and an
increase in the total annual time burden
from six hours in 2018 to 48 hours
(n=42 more hours).
khammond on DSKJM1Z7X2PROD with NOTICES
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Type of respondents
Form name
State or Local Governments (or their bona
fide fiscal agents).
ALPA Web Survey .........................................
ALPA Email Survey ........................................
VerDate Sep<11>2014
20:15 Nov 03, 2020
Jkt 253001
PO 00000
Frm 00026
Fmt 4703
Sfmt 4703
E:\FR\FM\04NON1.SGM
Number of
responses per
respondent
60
1
04NON1
1
1
Average
burden
per
response
(in hours)
47/60
47/60
Federal Register / Vol. 85, No. 214 / Wednesday, November 4, 2020 / Notices
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Scientific Integrity, Office of Science,
Centers for Disease Control and Prevention.
[FR Doc. 2020–24474 Filed 11–3–20; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Framework for Conditional Sailing and
Initial Phase COVID–19 Testing
Requirements for Protection of Crew
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice.
AGENCY:
The Centers for Disease
Control and Prevention (CDC), a
component of the Department of Health
and Human Services (HHS), announces
a framework for a phased resumption of
cruise ship passenger operations. CDC
also announces requirements for the
initial phases of this framework
regarding testing of crew members for
COVID–19, an integral part of the initial
phases prior to resuming passenger
operations. This Order applies to cruise
ship operators with cruise ships
operating in U.S. waters and cruise ship
operators who are operating cruise ships
outside of U.S. waters, but intend for
their cruise ships to return to operating
in U.S. waters while this Order remains
in effect.
DATES: This action is effective October
30, 2020.
FOR FURTHER INFORMATION CONTACT:
Jennifer Buigut, Division of Global
Migration and Quarantine, Centers for
Disease Control and Prevention, 1600
Clifton Road NE, MS H16–4, Atlanta,
GA 30329. Phone: 404–498–1600.
Email: dgmqpolicyoffice@cdc.gov.
SUPPLEMENTARY INFORMATION: This
Order establishes a framework for a
phased approach to resuming cruise
ship passenger operations in U.S.
waters. This phased approach will
include: (1) Establishment of laboratory
testing of crew onboard cruise ships in
U.S. waters; (2) simulated voyages
designed to test a cruise ship operators’
ability to mitigate COVID–19 onboard
cruise ships; (3) a certification process;
and (4) a return to passenger voyages in
a manner that mitigates the risk of
COVID–19 introduction, transmission,
or spread among passengers and crew
onboard ships and ashore to
communities.
khammond on DSKJM1Z7X2PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
18:16 Nov 03, 2020
Jkt 253001
70153
As part of the initial crew testing
phases, this Order additionally contains
requirements for: (1) Shoreside COVID–
19 laboratory screening testing of all
crew currently onboard cruise ships; (2)
onboard diagnostic testing capabilities
for symptomatic travelers (crew and
future passengers); (3) shoreside
COVID–19 laboratory screening testing
of all newly embarking crew; and (4)
continued compliance with complete,
accurate, and acknowledged, No Sail
Order Response Plans.
A copy of the Order is provided below
and a copy of the signed order can be
found at https://www.cdc.gov/
quarantine/cruise/.
phases are subject to change based on
public health considerations and cruise
ship operators’ demonstrated ability to
mitigate COVID–19 risk. CDC will issue
additional orders as needed that will be
published in the Federal Register and
technical instructions that will be
subsequently posted on CDC’s website.
This Order additionally announces
requirements for the initial phases
relating to crew testing. CDC considers
adequate crew safeguards as
demonstrated through laboratory testing
for SARS coronavirus 2 (SARS–CoV–2),
the virus that causes COVID–19, an
integral part of the initial phases prior
to resuming passenger operations.
U.S. Department of Health and Human
Services (HHS)—Centers for Disease
Control and Prevention (CDC)
Previous Orders and Incorporation by
Reference
Order Under Sections 361 & 365 of the
Public Health Service Act (42 U.S.C.
264, 268) and 42 Code of Federal
Regulations Part 70 (Interstate) and
Part 71 (Foreign): Framework for
Conditional Sailing and Initial Phase
COVID–19 Testing Requirements for
Protection of Crew
Executive Summary
The Centers for Disease Control and
Prevention (CDC), a component of the
U.S. Department of Health and Human
Services (HHS), announces this
framework for a phased resumption of
cruise ship passenger operations.
Considering the continued spread of
COVID–19 worldwide and increased
risk of COVID–19 on cruise ships, a
careful approach is needed to safely
resume cruise ship passenger
operations. CDC is establishing
requirements to mitigate the COVID–19
risk to passengers and crew, prevent the
further spread of COVID–19 from cruise
ships into U.S. communities, and
protect public health and safety. After
expiration of CDC’s No Sail Order (NSO)
on October 31, 2020, CDC will take a
phased approach to resuming cruise
ship passenger operations in U.S.
waters.
The initial phases will consist of
testing and additional safeguards for
crew members. CDC will ensure cruise
ship operators have adequate health and
safety protections for crew members
while these cruise ship operators build
the laboratory capacity needed to test
future passengers. Subsequent phases
will include simulated voyages to test
cruise ship operators’ ability to mitigate
COVID–19 risk, certification for ships
that meet specific requirements, and a
phased return to cruise ship passenger
voyages in a manner that mitigates
COVID–19 risk among passengers, crew
members, and U.S. communities. These
PO 00000
Frm 00027
Fmt 4703
Sfmt 4703
The findings and other evidence
relied upon in issuing the No Sail Order
and Other Measures Related to
Operations signed by the CDC Director
on March 14, 2020,1 as further modified
and extended effective April 15, 2020,2
July 16, 2020,3 and September 30,
2020 4—are incorporated herein by
reference.
Statement of Intent
This Order shall be interpreted and
implemented in a manner as to achieve
the following paramount objectives:
• Preserving human life;
• Preserving the health and safety of
cruise ship crew members, port
personnel, and communities;
• Preventing the further introduction,
transmission, and spread of COVID–19
into and throughout the United States;
• Preserving the public health and
other critical resources of Federal, State,
and local governments;
1 No Sail Order and Suspension of Further
Embarkation. https://www.federalregister.gov/
documents/2020/03/24/2020-06166/no-sail-orderand-suspension-of-further-embarkation. Last
accessed October 19, 2020.
2 No Sail Order and Suspension of Further
Embarkation; Notice of Modification and Extension
and Other Measures Related to Operations. https://
www.federalregister.gov/documents/2020/04/15/
2020-07930/no-sail-order-and-suspension-offurther-embarkation-notice-of-modification-andextension-and-other. Last accessed October 19,
2020.
3 No Sail Order and Suspension of Further
Embarkation, Second Modification and Extension of
No Sail Order and Other Measures Related to
Operations. https://www.federalregister.gov/
documents/2020/07/21/2020-15810/no-sail-orderand-suspension-of-further-embarkation-secondmodification-and-extension-of-no-sail. Last
accessed October 19, 2020.
4 No Sail Order and Suspension of Further
Embarkation; Third Modification and Extension of
No Sail Order and Other Measures Related to
Operations. https://www.federalregister.gov/
documents/2020/10/05/2020-22030/no-sail-orderand-suspension-of-further-embarkation-thirdmodification-and-extension-of-no-sail. Last
accessed October 19, 2020.
E:\FR\FM\04NON1.SGM
04NON1
]]>Agencies
[Federal Register Volume 85, Number 214 (Wednesday, November 4, 2020)]
[Notices]
[Pages 70151-70153]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-24474]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30Day-21-1215]
Agency Forms Undergoing Paperwork Reduction Act Review
In accordance with the Paperwork Reduction Act of 1995, the Centers
for Disease Control and Prevention (CDC) has submitted the information
collection request titled Awardee Lead Profile Assessment (ALPA) to the
Office
[[Page 70152]]
of Management and Budget (OMB) for review and approval. CDC previously
published a ``Proposed Data Collection Submitted for Public Comment and
Recommendations'' notice on July 20, 2020 to obtain comments from the
public and affected agencies. CDC did not receive comments related to
the previous notice. This notice serves to allow an additional 30 days
for public and affected agency comments.
CDC will accept all comments for this proposed information
collection project. The Office of Management and Budget is particularly
interested in comments that:
(a) Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
(b) Evaluate the accuracy of the agencies estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and clarity of the information to
be collected;
(d) Minimize the burden of the collection of information on those
who are to respond, including, through the use of appropriate
automated, electronic, mechanical, or other technological collection
techniques or other forms of information technology, e.g., permitting
electronic submission of responses; and
(e) Assess information collection costs.
To request additional information on the proposed project or to
obtain a copy of the information collection plan and instruments, call
(404) 639-7570. Comments and recommendations for the proposed
information collection should be sent within 30 days of publication of
this notice to www.reginfo.gov/public/do/PRAMain. Find this particular
information collection by selecting ``Currently under 30-day Review--
Open for Public Comments'' or by using the search function. Direct
written comments and/or suggestions regarding the items contained in
this notice to the Attention: CDC Desk Officer, Office of Management
and Budget, 725 17th Street NW, Washington, DC 20503 or by fax to (202)
395-5806. Provide written comments within 30 days of notice
publication.
Proposed Project
Awardee Lead Profile Assessment (ALPA) (OMB Control No. 0920-1215,
Exp. 02/28/2021)--Revision--National Center for Environmental Health
(NCEH), Centers for Disease Control and Prevention (CDC).
Background and Brief Description
The Centers for Disease Control and Prevention (CDC) is requesting
Paperwork Reduction Act (PRA) clearance for a three-year revised
information collection request (ICR) titled ``Awardee Lead Profile
Assessment (ALPA)'' (OMB Control No. 0920-1215; expiration date 02/28/
2021). The goal of this ICR is to build on the CDC's existing childhood
lead poisoning prevention program. Based on program successes over the
past three years, CDC has made ALPA an annual reporting requirement for
ongoing and new CDC Childhood Lead Poisoning Prevention Programs
(CLPPPs), including the FY17 ``Lead Poisoning Prevention--Childhood
Lead Poisoning Prevention--financed partially by Prevention and Public
Health Funds'' (CDC-RFA-EH17-1701PPHF17); the FY18 ``Childhood Lead
Poisoning Prevention Projects, State and Local Childhood Lead Poisoning
Prevention and Surveillance of Blood Lead Levels in Children'' (CDC-
RFA-EH18-1806); and the FY20 ``Childhood Lead Poisoning Prevention and
Surveillance of Blood Lead Levels in Children'' (CDC-RFA-EH20-2001).
This annual information collection will be used to; (1) identify common
characteristics of funded childhood lead poisoning prevention programs,
and (2) inform guidance and resource development in support of the
ultimate program goal, which is blood lead elimination in children.
The dissemination of these ALPA results will ensure that both
funded and non-funded jurisdictions are able to; (1) identify policies
and other factors that support or hinder childhood lead poisoning
prevention efforts; (2) understand what strategies are being used by
funded public health agencies to implement childhood lead poisoning
prevention activities; and (3) use this knowledge to develop and apply
similar strategies to support the national agenda to eliminate
childhood lead poisoning.
This program management information collection has been revised in
several ways. Due to an increase in funding and program growth, CDC is
requesting an increase in the number of respondents, defined as state
and local governments, or their bona fide agents.
CDC will continue to use two data collection modes, a web survey
and an email survey. We anticipate that most of the respondents (n=60;
98 percent) will use the web survey. The estimates of the number and
percentage of respondents by mode of data collection are based on
previous data collections. In the past, respondents only used the email
survey if they had technical difficulties with the web survey, which
was rare. For this purpose, we estimate that only 2% (n=1) of the
respondents may need to submit an email survey. This represents a
change in distribution from the 2018 estimates, which were initially
assumed as 83.3% for the web survey and 16.7% for the email survey.
A redistribution by mode of collection will not affect the total
time burden requested as the time per response is the same for either
mode; however, the time to take the survey has increased from seven
minutes in 2018 to 47 minutes per response due to a revision of the
survey. This revised time estimate per response is based on pilot tests
of the revised survey among nine respondents, and includes the time
needed to review the ALPA Training Manual, which is a new addition in
this revision ICR.
Thus, CDC is requesting an increase in the annual number of
respondents from 48 to a maximum of 61 recipients (n=13 more
respondents), and an increase in the total annual time burden from six
hours in 2018 to 48 hours (n=42 more hours).
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Type of respondents Form name Number of responses per per response
respondents respondent (in hours)
----------------------------------------------------------------------------------------------------------------
State or Local Governments (or their ALPA Web Survey......... 60 1 47/60
bona fide fiscal agents). ALPA Email Survey....... 1 1 47/60
----------------------------------------------------------------------------------------------------------------
[[Page 70153]]
Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Scientific
Integrity, Office of Science, Centers for Disease Control and
Prevention.
[FR Doc. 2020-24474 Filed 11-3-20; 8:45 am]
BILLING CODE 4163-18-P
